Don't throw in the bin, please flush it! CDSCO dictum for these 17 medicines Farhat Nasim31 May 2025 6:21 PM ISTNew Delhi: In a move to streamline the disposal of expired or unused medicines, the Central Drugs Standard Control Organisation (CDSCO) has issued a...
Dr Reddy's Gets SEC Nod for Higher Semaglutide Dose in Ongoing Phase III Study, Govt Sites Mandated Dr. Divya Colin30 May 2025 8:14 PM ISTNew Delhi: In response to the proposal presented by the Dr Reddy's Laboratories, the Subject Expert Committee (SEC) functional under the Central Drug...
Only Licensed Importers Can Overprint Labels Under Rule 104A, Clarifies CDSCO Dr. Divya Colin29 May 2025 8:05 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has clarified that overprinting or stickering of drug products under the Drugs...
CDSCO Panel Accepts BE Report, Tells Intas Pharma to Conduct Phase III Trial for Semaglutide Dr. Divya Colin28 May 2025 3:00 PM ISTNew Delhi: In response to a proposal submitted by Intas Pharmaceuticals, the Subject Expert Committee (SEC) under the Central Drugs Standard Control...
PCI Orders Pharmacy Colleges to Submit UGC Anti-Ragging Compliance Report by June 1 Farhat Nasim27 May 2025 7:38 PM ISTNew Delhi: The Pharmacy Council of India (PCI) has issued a directive to all pharmacy institutions under its purview to strengthen their compliance...
CDSCO Panel Clears Abbott's Phase IV Trial for Empagliflozin + Metformin FDC, Seeks More Sites Dr. Divya Colin26 May 2025 8:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to Abbott Healthcare...
Delhi HC Quashes IPO's Patent Rejection of Taiho Pharma's Cancer Drug, Orders Re-evaluation Farhat Nasim25 May 2025 4:00 PM ISTNew Delhi: In a ruling impacting pharmaceutical patent jurisprudence in India, the Delhi High Court has set aside the Indian Patent Office's (IPO)...
Macleods Gets CDSCO Panel Go Ahead For Semaglutide Trials, Preclinical Data Sought Farhat Nasim24 May 2025 9:54 PM ISTNew Delhi: The Subject Expert Committee (SEC) on Endocrinology and Metabolism, operating under the Central Drugs Standard Control Organisation...
Zydus Told to Withdraw Unmarketed Strengths, Conduct Phase IV Trial for Approved Combinations Only Dr. Divya Colin23 May 2025 9:44 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has directed Zydus Healthcare Ltd. to...
Drug alert: CDSCO flags 60 formulations as not of standard quality Ruchika Sharma22 May 2025 5:05 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has flagged sixty drug batches for failing to qualify for a random drug sample...
Eli Lilly Gets CDSCO Panel Nod To import, and market anticancer Selpercatinib Tablets Dr. Divya Colin21 May 2025 6:00 PM ISTNew Delhi: Pharmaceutical major Eli Lilly has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
USFDA Flags Sarfez Pharma for Misleading Promotion of Torsemide Drug Soaanz Farhat Nasim20 May 2025 8:24 PM ISTUS: In a stern regulatory move, the United States Food and Drug Administration (USFDA) has issued a warning letter to Virginia-based Sarfez...
